Is there a role for Gallium-67 SPECT in distinguishing progression and pseudoprogresion in oncologic patients receiving immunotherapy?

Is there a role for Gallium-67 SPECT in distinguishing progression and pseudoprogresion in oncologic patients receiving immunotherapy?

Immuno-oncology (IO) with immune checkpoint inhibitors (ICIs) is the new landmark in cancer treatment. However, due to its economical-related burden and the possibility of tumor pseudoprogression with late response patterns, it is imperative to find new ways for early discrimination of patients with...

Full description

Bibliographic Details
Main Authors: Davide Mauri, Spyridon Tsiouris, Stefania Gkoura, Ioanna Gazouli, Panagiotis Ntellas, Annalea Amylidis, Lefteris Kampletsas, Andreas Fotopoulos
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Immuno-oncology
Immune checkpoint inhibitor
Pseudoprogression
‘Hot’ & ‘cold’ tumor
Gallium-67
SPECT/CT
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294221001386

Internet

http://www.sciencedirect.com/science/article/pii/S2468294221001386

Similar Items